Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Laryngoscope. 2014 Aug 11;124(11):2619–2623. doi: 10.1002/lary.24647

The Forced-Response Test Does Not Discriminate Ears with Different Otitis Media Expressions

Margaretha L Casselbrant 1, Ellen M Mandel 1, James T Seroky 1, J Douglas Swarts 1, William J Doyle 1
PMCID: PMC4136992  NIHMSID: NIHMS570819  PMID: 24550093

Abstract

Objective

Test the hypothesis that the Eustachian tube (ET) function measured using standard manometric test methods is different between groups of ears with tympanostomy tubes inserted for recurrent acute otitis media (RAOM) and for chronic otitis media with effusion (COME).

Study Design

A cross-sectional study of ET function in populations of young children with different otitis media expressions.

Methods

The results for Forced-Response testing of ET function were compared using a general linear model between 37 ears of 26 children and 34 ears of 26 children aged 3 and 4 years old with ventilation tubes inserted for COME and RAOM, respectively.

Results

There were no significant between-group differences in either the active measure of ET opening function, dilatory efficiency, or in the passive measures reflecting the magnitude of the forces that tend to hold the ET lumen closed, the opening and closing pressures and passive transET conductance.

Conclusions

The results do not support the hypothesis that ET closing forces are less in ears with RAOM when compared to ears with COME and, from the results of earlier studies, ears without disease. Both groups were characterized by a low ET opening efficiency (referenced to ears of adults with no disease history). Because both disease expressions present the same pattern of ET dysfunction, other factors are required to explain why a subset of ears with that type of dysfunction develop RAOM, as opposed to the default expression of COME.

Keywords: Eustachian tube, Function Tests, Recurrent Acute Otitis Media, Chronic Otitis Media with Effusion

INTRODUCTION

Otitis media (OM) is a common disease in young children that also affects adolescents and adults. The disease is characterized by inflammation of the middle-ear (ME) mucosa and an effusion within the usually gas-filled ME cavity1. OM onset can be either symptomatic, acute OM (AOM), or asymptomatic, OM with effusion (OME), and most frequently occurs as a complication of a viral upper respiratory tract infection2. AOM is believed to be caused by the transfer of nasopharyngeal pathogens to the ME via the Eustachian tube (ET) with subsequent ME mucosal infection, and OME is believed to be a consequence of ME pressure dysregulation secondary to an ET blockage. Both presentations can evolve to a persistent, relatively asymptomatic, ME mucosal inflammation that can last from months to years, chronic OME (COME). Also, both presentations can exhibit a pattern of frequent recurrences, with recurrent AOM (RAOM) being particularly worrisome to affected patients and their caregivers1. Extant ME effusion may be accompanied by a significant conductive hearing loss and balance disturbance and, thus, contributes to patient morbidity3,4. At present, there is no highly effective medical or surgical procedure that promotes a long-term cure of COME or prevents RAOM, though surgical insertion of ventilation tubes (VTs), at least temporarily, clears the effusion, resolves the ME mucosal inflammation, and improves hearing and balance5.

Past clinical and experimental research evidence a central role for adequate ET function (ETF) in maintaining ME health6. The ET represents a potential communication between the ME and nasopharynx for the exchange of gas, pathogens and debris between those compartments. The ET is usually closed which isolates the ME from nasopharyngeal pathogens and pressures and is actively opened periodically by contraction of the Tensor Veli Palatini muscle (mTVP) which allows for gas flow between those compartments to stabilize ME pressure at approximate ambient levels. Bluestone broadly defined poor ET function (i.e. ET dysfunction) as an ET that is either “too open”, facilitating ME access for nasopharyngeal pathogens and pressures, or “too closed”, disrupting normal ME pressure regulation7. In his classification, ET dysfunction caused by insufficient closing forces (e.g. a patulous or semi-patulous ET) would promote the development of AOM and its recurrence as RAOM, while ET dysfunction secondary to poor ET opening efficiency causes the development of OME and its persistence as COME. In that regard, the implicit causal relationship between poor ET opening efficiency and OME/COME is well established by experimental8,9 and clinical studies1014, but that between a “too open” ET and risk for AOM and/or RAOM remains largely conjectural9.

There are a number of tests designed to evaluate ETF, but relatively few capture information on both the active (e.g. ET opening efficiency) and passive (e.g. ET closing forces) properties of the ET6. The Forced-Response test (FRT) originally described by Cantekin and colleagues10 was designed to assess simultaneously these two classes of ET properties but requires direct access to the ME via a perforation or functional VT in the tympanic membrane which is uncommon in individuals not being treated with VTs for extant or recent disease. However, because VTs are commonly used to treat both COME and RAOM and past studies show that the passive properties of the ET are not different between ears with COME and those without a significant disease history10,11,14, that test can be used to evaluate the validity of the hypothesized low tubal closing forces in ears with RAOM. Specifically, the hypothesis would be supported if the FRT measures of the tubal closing pressure are less and the transET conductance greater in ears with VTs inserted for RAOM when compared to ears with VTs inserted for COME. Here, we report the results for that comparison between groups of children aged 3 and 4 years old with RAOM or COME and test the stated hypothesis.

METHODS

Our laboratory has been conducting a number of longitudinal studies that include evaluations of ETF by the FRT in children aged 3 through 7 years old with COME and RAOM. For those studies, COME is defined as ≥3 months of bilateral ME effusion or ≥6 months of unilateral ME effusion or ≥3 episodes of OME during the past year, or recurrence of OME after extrusion of previous VTs for OME; RAOM is defined as a history of ≥3 AOM episodes in 6 months or of ≥4 AOM episodes in 12 months15. The two studies from which the present data were extracted excluded subjects if they had cleft palate or other syndromes predisposing to OM, a history of complications of OM or its treatment, or were unable to cooperate with the testing. Both were approved by the Institutional Review Board at the University of Pittsburgh, and written Informed Consent was obtained from a parent before enrolling their child in either study. We abstracted from those databases the first complete FRT done between the ages of 36 to 59 months on ears of children with VTs inserted for either COME or RAOM to include in these analyses.

The FRT protocol was standardized across all studies10. Briefly, a probe was introduced and sealed into the ear canal ipsilateral to the ET being evaluated. The probe was coupled serially to a flow sensor, pressure transducer and then, via a valve, to a constant flow pump. For testing, the pump delivered ≈23 ml/min of air-flow (QO) to the ME. This caused ME pressure to increase and the ET to open passively at a measured pressure (opening pressure-PO). Continued delivery of air-flow resulted in a semi-stable system (i.e. intraluminal ET) pressure (PS) and transtubal air-flow (QS) which was approximately equal to QO. The child was instructed or induced to swallow, an activity associated with mTVP contraction, and the pre-swallow system pressure (PA) and maximum transtubal air-flow during the swallow (QA) were recorded. After the air-flow had returned to the pre-swallow level, the pump was turned off, allowing the ET to close passively while retaining a residual ME pressure (closing pressure-PC). Passive ET conductance (CS; 1/resistance) was calculated as QS/PS and active ET conductance (CA) was calculated as QA/PA. The ratio of active to passive conductance (CA/CS) is defined as the dilatory efficiency (DE). When possible, the test was repeated on the contralateral ET using an identical procedure.

All analyses of the FRT pressure-flow waveforms were done independently by two technicians, and these data were reconciled prior to inclusion in the study database. Three FRT passive ET function parameters, PO, PC and CS, and 1 active ET function parameter, DE were analyzed in this report. The ET opening pressure, PO, is a measure of the combined extra- and intraluminal forces acting to maintain a closed ET lumen. The ET closing pressure, PC, is a measure of the extra-luminal force acting to maintain a closed ET lumen. Passive conductance, CS, is a measure of the distensibility of the ET lumen in response to applied intraluminal pressures. Dilatory efficiency, DE, is a measure of the efficiency of mTVP activity to effect luminal dilation.

Here, we asked two questions. Are the values of the passive FRT parameters different between RAOM and COME ears, and can those parameter when measured in a mixed population of ears accurately assign test ears to their respective group? To address the first question, for each passive function parameter, we used a general linear model to determine if group assignment explained a significant percent of the measured variance in the parameter. There, group was entered as the primary explanatory factor and age, sex, race and laterality were entered as covariates. In a secondary analysis based on our directional hypothesis, we used a 1-tailed Student’s “t” test to determine if the values for PO and PC are significantly less and the values for CS significantly greater in the RAOM group when compared to the COME group. For the active function parameter, DE, our hypothesis makes no directional prediction with respect to between-group differences. Because the distributions of DE for each group were highly skewed (not normal), we compared the DE values between groups using a normal approximation to a 2-tailed, non-parametric Mann-Whitney U test. To address the second question, we used a logistic regression model that simultaneously entered the values for the 3 passive function parameters as predictors of group assignment and determined the significance of the contribution of each parameter to group discrimination14. All analyses were done using the NCSS 2007 statistical software package (Kaysville, Utah).

Under the hypothesis that RAOM ears are characterized by low ET closing forces reflecting a low resistance exchange pathway between the nasopharynx and ME, we expect that PC would be significantly lower and CS significantly higher in the RAOM group when compared to the COME group (which from past studies in adults are not different from a “disease-free” group11,14) and that the model equation including those 3 parameters accurately assigns ears to their respective group. We make no prediction as to the relative values of the DE for the 2 groups but note that, from past research on adults, DE in COME ears was significantly less than that measured in ears without a history of ME disease and DE is an accurate predictor of ear assignment to the COME group in a mixed population of ears with COME and with no significant history of ME disease10,11,14,16.

RESULTS

The study population consisted of 26 children (11 male; 23 white, 3 non-white; avg. age=4.0±0.6 years) with VTs inserted for COME and 26 children (17 male; 20 white, 6 non-white; avg. age=3.7±0.5 years) with VTs inserted for RAOM. ETF was evaluated by the FRT for 37 (16 right) and 34 (19 right) ears of the children in the COME and RAOM groups, respectively.

Table I summarizes the average and standard deviation of the 3 FRT passive function parameters for the 2 groups, and the value of the “F” statistic and probability level for the between-group comparisons when controlled for age, sex, laterality and race. None of the between-group comparisons was statistically significant. Under the directional hypothesis that the average value for the closing pressure is higher and that for passive conductance lower in the COME group when compared to the RAOM group, the Student’s “t” value and associated 1-tailed probability were t=0.43, p= 0.33 for the ET closing pressure and t=0.01, p=0.50 for the passive ET conductance. None of these differences was statistically significant. The median value and range of ET dilatory efficiency for the COME and RAOM groups were 2.20 (range: 0.07 to 30.24) and 1.81 (range: 0.01 to 85.00), respectively. The distribution of dilatory efficiencies was not significantly different between the groups (Z=−1.51, p=0.13).

TABLE I.

Summary Data

PO23 PC23 CS23 DE23
COME Avg 324.9 91.6 0.15 3.80
Std 124.4 59.1 0.08 5.32
RAOM Avg 302.8 85.6 0.15 4.68
Std 94.8 40.1 0.06 14.37
Test F-Value* 1.23 0.43 0.57 0.07
P-Value 0.27 0.51 0.45 0.79

PO23=opening pressure, PC23=closing pressure, CS23=passive conductance, DE23=dilatory efficiency

*

Calculated after adjusting for age, ear, race and sex

Table II reports the results of the logistic regression analysis. Alone, none of the passive function parameters was a significant predictor of group assignment, the significance level for the model was 0.09, and the percent variance explained by the model was only 4% (r2=0.04). For the assignment of ears to the COME group, the percent correctly classified by the regression equation was 61%, and the sensitivity and specificity of the model for that assignment were 54% and 68%, respectively.

TABLE II.

Logistic Regression Analysis

Intercept PO23 PC23 CS23 DE23
Beta Coefficient 1.529 −0.003 −0.002 −1.659 0.027
Standard Error 1.669 0.004 0.007 5.061 0.043
Z-Value 0.916 −0.772 −0.320 −0.328 0.628
P-Level 0.360 0.440 0.749 0.743 0.530

PO23=opening pressure, PC23=closing pressure, CS23=passive conductance, DE23=dilatory efficiency

DISCUSSION

Under the tested hypothesis, we expected that there would be significant between-group differences in the FRT parameters reflecting the passive properties of the ET and, specifically, that the ET passive conductance would be higher and the ET closing pressure lower in the RAOM group. We also expected that, when combined, the FRT passive parameters would accurately assign tested ears to their respective group. Our results were not consistent with those expectations and, thus, fail to support the hypothesis. There, none of the 3 passive parameters was significantly different between the RAOM and COME groups despite our reasonable power to detect physiologically meaningful differences. Specifically, the group sample sizes of 34 and 37 ears had more than 80% power to detect a between-group difference of ≥30% for all passive function variables. One published “pilot” study with smaller group sizes reported that ET passive resistance (1/conductance) was significantly higher, not lower, in ears with RAOM when compared to ears with COME but documented no between-group differences in ET opening and closing pressures15. Because the passive measures of ETF in adults are not different between ears with COME and those without a significant ME disease history11,14,16, we extend this equality to comparisons of the passive measures of ETF among RAOM, COME and healthy ears. Together, these results suggest that a low resistance ET pathway for gas and material exchange between the ME and nasopharynx is not sole and sufficient for the development of RAOM in young children.

Past research convincingly showed that ET dysfunction in ears with VTs inserted to treat COME is characterized by an inefficient muscle-assisted ET opening mechanism10,12,14,16 and animal experiments showed that experimentally debilitating mTVP muscle function caused COME that was not resolved until muscle function was re-established, or VTs were inserted as an alternative pathway for ME pressure regulation8,9. In this study, ET dilatory efficiency, the FRT measure of ET opening efficiency, was not different in the ears with VTs inserted to treat COME or RAOM, and, for both groups, median dilatory efficiency was comparable to that measured previously for 23 adult ears with extant physician-diagnosed ET dysfunction/COME (median DE =1.74, range=0.13 to 7.81) but was less than that measured previously for 25 adult ears with no concurrent ME disease or past history of OM (median DE =3.68; range=0.04 to 10.35)14. While the hypothesis tested here does not specify directional differences in dilatory efficiency between the RAOM and COME groups, the similarity of the values for dilatory efficiency when combined with the similarity for measures of the passive function parameters show that ETF, as measured by the FRT, cannot be used to assign ears to RAOM and COME groups.

Accepting a causal role for ETF in the pathogenesis of the different OM expressions, our result was unexpected but can be explained if a secondary factor(s) superimposed on poor ET opening efficiency changes the trajectory of disease pathogenesis from the assumed default condition, COME to RAOM. In that regard, a number of host (e.g. immunological deficiencies) and environmental (e.g. day care) factors have been identified as being more prevalent in the population of children with diagnosed RAOM when compared to age-matched children without significant ME disease. Usually, these factors are considered to be RAOM “risk modifiers”5,17,18. In light of our results, a better approach to identify RAOM risk factors may be to compare the distribution of candidate factors between children with RAOM and those with COME, since this would control for the contribution of ET dysfunction to RAOM risk. The feasibility of this strategy for RAOM risk factor identification is being explored in ongoing studies.

This data interpretation presumes that the FRT captures all information on ETF important for defining the role(s) played by ET dysfunction in OM pathogenesis. In that regard, past studies show that ET dilatory efficiency correlates with the measures of ET opening efficiency available for other tests14, accurately predicts group assignment in a mixed population of ears with COME and no history of ME disease14, and, with other factors, identifies ears likely to develop COME recurrence after VTs inserted for the condition become non-functional13. For these reasons, we have confidence that dilatory efficiency is a physiologically relevant measure of ETF. In contrast, with the exceptions of extreme variants in ET dysfunction, such as a patulous ET lumen (closing pressure = 0 daPa) or a physically obstructed ET lumen (opening pressure > 1000 daPa), FRT measures of the passive tubal properties have not been clearly related to any pathological expression. Nonetheless, these measures characterize the physical properties of the ET and existing evidence suggests that those properties constrain and limit the muscle-assisted tubal opening efficiency14. While the parameters of the FRT characterize ETF as currently understood and include measures analogous to those for other existing ETF tests, whether or not they represent a complete description of ETF remains a question open to continued review as our knowledge of this important area of physiology expands.

Here, we also assumed that ETF measured in ears with VTs inserted for RAOM or for COME reflects the pre-VT, constitutive ETF underlying pathogenesis of those disease expressions. However, it is possible that the post-VT, ETF assessments measure a transient state of dysfunction attributable to the extension of the extant ME mucosal inflammation to the ET lumen. If true, the characteristic pattern of ET dysfunction would be similar for ears with VTs inserted for RAOM and for COME since both disease conditions are associated with ME mucosal inflammation. Two lines of evidence argue against this possibility. First, FRTs in adults with healthy ears and no history of ME disease, with healthy ears but with a history of ME disease in childhood, and with VTs inserted as a treatment for current COME, show similar values for all groups in the passive function parameters but a graded dilatory efficiency from high to intermediate to low, respectively for those groups14,16. The most parsimonious explanation for this finding is that, while the healthy ears with a history of ME disease in childhood had outgrown their constitutive ET dysfunction and COME risk, they retain a low level constitutive dysfunction that is not of sufficient magnitude to provoke pathology. Second, ME mucosal inflammation resolves during the time with functional VTs. If ET dysfunction is a consequence and not the cause of ME inflammation, it is expected that ETF would improve over the period of time with functional VTs. However, a number of longitudinal studies have shown that ETF as measured by the FRT and other tests is not affected by the time with functional VTs19,20.

CONCLUSIONS

The present study of ETF in young children with VTs inserted as a treatment for RAOM or COME showed a similar profile in the two groups. There was no evidence that ETF in RAOM ears was characterized by a pattern indicative of ET closing failure as was hypothesized. Rather, the FRT results suggest a debility in the active, muscle-assisted opening mechanism for both disease expressions. Further studies are needed to explore the patient characteristics which predispose subsets of the ears with poor ET opening efficiency to develop RAOM, as opposed to the expected disease expression, COME.

Acknowledgments

This study was supported in part by a grant from the National Institutes of Health (P50 DC007667), and by the Hamburg and Eberly Endowments to the Division of Pediatric Otolaryngology, University of Pittsburgh. These sources provided funding for the study, but did not have input into the design, analyses or interpretation of the data. The investigators thank Ms. Kathy Tekely, RN, MSN for assisting with subject recruitment and Juliane Banks, BA, Maria Swarts, BA and Jenna El-Wagaa for assistance with data abstraction and formatting.

Footnotes

Financial Disclosures: None to declare.

CONFLICT OF INTEREST STATEMENT

None of the authors has a conflict of interest to declare regarding this manuscript.

Level of Evidence: 2b –individual cohort study

References

  • 1.Bluestone CD, Klein JO. Otitis Media in Infants and Children. 5. Ontario: B. C. Decker, Inc; 2007. [Google Scholar]
  • 2.Mandel EM, Doyle WJ, Winther B, Alper CM. The incidence, prevalence and burden of OM in unselected children aged 1–8 years followed by weekly otoscopy through the “common cold” season. Int J Pediatr Otorhinolaryngol. 2008 Apr;72(4):491–499. doi: 10.1016/j.ijporl.2007.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Casselbrant ML, Furman JM, Rubenstein E, Mandel EM. Effect of otitis media on the vestibular system in children. Ann Otol Rhinol Laryngol. 1995 Aug;104(8):620–624. doi: 10.1177/000348949510400806. [DOI] [PubMed] [Google Scholar]
  • 4.Klein JO. The burden of otitis media. Vaccine. 2000 Dec 8;19( Suppl 1):S2–8. doi: 10.1016/s0264-410x(00)00271-1. [DOI] [PubMed] [Google Scholar]
  • 5.Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet. 2004 Feb 7;363(9407):465–473. doi: 10.1016/S0140-6736(04)15495-0. [DOI] [PubMed] [Google Scholar]
  • 6.Bluestone CD. Eustachian Tube Structure, Function, Role in Otitis Media. Hamilton, Ontario: BC Decker Inc; 2005. [Google Scholar]
  • 7.Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. 1996 Apr;15(4):281–291. doi: 10.1097/00006454-199604000-00002. [DOI] [PubMed] [Google Scholar]
  • 8.Cantekin EI, Bluestone CD, Saez CA, Doyle WJ, Phillips DC. Normal and abnormal middle ear ventilation. Ann Otol Rhinol Laryngol Suppl. 1977 Jul-Aug;86(4 Pt 3 Suppl 41):1–15. doi: 10.1177/00034894770864s201. [DOI] [PubMed] [Google Scholar]
  • 9.Doyle WJ. Animal models of otitis media: other pathogens. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S45–47. [PubMed] [Google Scholar]
  • 10.Cantekin EI, Saez CA, Bluestone CD, Bern SA. Airflow through the eustachian tube. Ann Otol Rhinol Laryngol. 1979 Sep-Oct;88(5 Pt 1):603–612. doi: 10.1177/000348947908800504. [DOI] [PubMed] [Google Scholar]
  • 11.Swarts JD, Bluestone CD. Eustachian tube function in older children and adults with persistent otitis media. Int J Pediatr Otorhinolaryngol. 2003 Aug;67(8):853–859. doi: 10.1016/s0165-5876(03)00127-7. [DOI] [PubMed] [Google Scholar]
  • 12.Alper CM, Losee JE, Mandel EM, Seroky JT, Swarts JD, Doyle WJ. Pre- and post-palatoplasty Eustachian tube function in infants with cleft palate. Int J Pediatr Otorhinolaryngol. 2012 Mar;76(3):388–391. doi: 10.1016/j.ijporl.2011.12.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Mandel EM, Swarts JD, Casselbrant ML, et al. Eustachian tube function as a predictor of the recurrence of middle ear effusion in children. Laryngoscope. 2013 Apr 10; doi: 10.1002/lary.24021. Epub ahead of print. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Doyle WJ, Swarts JD, Banks J, Casselbrant ML, Mandel EM, Alper CM. Sensitivity and specificity of eustachian tube function tests in adults. JAMA Otolaryngol Head Neck Surg. 2013 Jul 1;139(7):719–727. doi: 10.1001/jamaoto.2013.3559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Casselbrant ML, Mandel EM, Seroky JT, Swarts JD, Doyle WJ. A pilot study of the ability of the forced response test to discriminate between 3-year-old children with chronic otitis media with effusion or with recurrent acute otitis media. Acta Otolaryngol. 2011 Nov;131(11):1150–1154. doi: 10.3109/00016489.2011.603137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Swarts JD, Alper CM, Mandel EM, Villardo R, Doyle WJ. Eustachian tube function in adults without middle ear disease. Ann Otol Rhinol Laryngol. 2011 Apr;120(4):220–225. doi: 10.1177/000348941112000401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Faden H. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 2001 Jul;160(7):407–413. doi: 10.1007/s004310100754. [DOI] [PubMed] [Google Scholar]
  • 18.Pelton SI, Leibovitz E. Recent advances in otitis media. Pediatr Infect Dis J. 2009 Oct;28(10 Suppl):S133–137. doi: 10.1097/INF.0b013e3181b6d81a. [DOI] [PubMed] [Google Scholar]
  • 19.Beery QC, Doyle WJ, Cantekin EI, Bluestone CD. Longitudinal assessment of Eustachian tube function in children. Laryngoscope. 1979 Sep;89(9 Pt 1):1446–1456. doi: 10.1002/lary.5540890910. [DOI] [PubMed] [Google Scholar]
  • 20.Doyle WJ, Mandel EM, Seroky JT, Swarts JD, Casselbrant ML. Reproducibility of the forced response test in children with chronic otitis media with effusion. Otol Neurotol. 2013 Jan;34(1):16–21. doi: 10.1097/MAO.0b013e31827853f4. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES